| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:c-ABL-IN-3
CAS:2626934-64-1
Package:50mg/RMB 13800;100mg/RMB 17500;25mg/RMB 10600
|
3-Pyridinecarboxamide, 1,6-dihydro-6-oxo-1-(5-pyrimidinyl)-N-[4-(trifluoromethoxy)phenyl]- manufacturers
- c-ABL-IN-3
-
- $1980.00 / 50mg
-
2025-04-29
- CAS:2626934-64-1
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | 3-Pyridinecarboxamide, 1,6-dihydro-6-oxo-1-(5-pyrimidinyl)-N-[4-(trifluoromethoxy)phenyl]- Basic information |
| | 3-Pyridinecarboxamide, 1,6-dihydro-6-oxo-1-(5-pyrimidinyl)-N-[4-(trifluoromethoxy)phenyl]- Chemical Properties |
| Boiling point | 532.7±50.0 °C(Predicted) | | density | 1.516±0.06 g/cm3(Predicted) | | pka | 12.63±0.70(Predicted) |
| | 3-Pyridinecarboxamide, 1,6-dihydro-6-oxo-1-(5-pyrimidinyl)-N-[4-(trifluoromethoxy)phenyl]- Usage And Synthesis |
| Uses | c-ABL-IN-3 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-3 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2021048567A1, compound 50)[1]. | | References | [1] Michael J. RAWLING, et al. New compounds and methods. Patent WO2021048567A1. |
| | 3-Pyridinecarboxamide, 1,6-dihydro-6-oxo-1-(5-pyrimidinyl)-N-[4-(trifluoromethoxy)phenyl]- Preparation Products And Raw materials |
|